Related Experiment Video
Updated: Sep 18, 2025

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
[Translated article] Multiple Basal Cell Carcinomas. Timeline and Underlying Risk Factors
Ricardo Fernández-de-Misa1, María Montes-de-Oca2, Irene Loizate1
1Servicio de Dermatología, Complejo Hospitalario Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, Spain.
Introduction:
Between 29% and 53% of the patients who develop basal cell carcinoma (BCC) will develop new BCCs.
Objectives:
Current objectives are to analyze the proportion and basic characteristics of patients who develop BCC >1, to delineate the concept of multiple BCC (mBCC) and be able to identify the factors associated with its development, and analyze its timeframe.
Patients And Method:
We conducted a retrospective observational study including all patients diagnosed with sporadic BCC from January 1st, 2014 through December 31st, 2014 at a tertiary referral center. Data included dates of BCCs, gender, age and histology of the first BCC, and the presence of BCC >1 at the initial appointment (cluster+). mBCC was defined as a patient who developed a series of BCCs >the 75th percentile of the series.
Results:
A total of 758 patients (51.2% men), were included. After a median follow-up of 100 months, 52.8% of the patients developed BCC >1. The 75th percentile of the number of BCCs was 3. Factors associated to mBCCs included being cluster+ (OR, 5.6; 95%CI, 3.2-9.7), being men (OR, 3.1; 95%CI, 2.0-4.8) and diagnosed with the first BCC between ages of 50 and 80 years (OR, 2.1; 95%CI, 1.3-3.5). After 5 years, 54% of patients exhibiting these three factors developed mBCC. The estimated median time to mBCC was 38.00 months (95%CI, 0-79.71).
Conclusions:
A quarter of patients who exhibit 1 BCC eventually develop four or more BCCs. Analyzing routine parameters may help identify individuals at a higher risk of developing mBCC and predict its timeframe.
More Related Videos
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer Prevention
Some...
Cancer
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
